Humanized Mouse Models Market Size To Be Worth $188.57 Million By 2030, Growing At A CAGR Of 9.54% During Forecast Period 2023-2030, Data By Contrive Datum Insights

According to a market research study published by Contrive Datum Insights, North America will hold the majority share of the global humanized mouse model market with 41.5% revenue in 2022, while Europe held the second-largest market share with a 33.4% share.

Farmington, March 19, 2023 (GLOBE NEWSWIRE) — The Humanized Mice Model Market The size was estimated at USD 95.72 million in 2022 and is projected to reach USD 188.57 million by 2030, growing at a CAGR of 9.54% from 2022 to 2030. Many imitations and inferior fruit purees have taken the place of fruit purees in recent years. Some of these have been noticed and banned around the world. People worry about where their raw fruit is coming from and are willing to pay a lot more for real goods. In response to consumer requests, some companies have added codes to their products so they can be traced back to specific farms around the world. Because of this, some pureed fruit products, like mashed avocado, can be used in many different ways.

Request a sample copy of the report “Humanized Mice Models Market – Global Industry Analysis, Size, Share, Growth Opportunities, Future Trends, Impact of Covid-19, SWOT Analysis, Competition and Forecasts 2022 to 2030‘, published by Contrive Datum Insights.

Humanized Mice Model Market Recent Developments:

• September 2021, genOway, a biotechnology company dedicated to the design and development of preclinical models, announced the acquisition of Axenis, a company dedicated to developing immunocompromised models to validate new and innovative therapeutics.

• In January 2022, Taconic Biosciences, a leading global provider of animal model solutions for drug discovery, announced the launch of the huNOG-EXL Early Access (EA) humanized immune system (HIS) mouse. This product expands Taconic’s widely used HIS portfolio. The huNOG-EXL EA significantly extends the duration of studies in which HIS mouse models of myeloid lineage can be successfully used.

• in October 2021, The Jackson Laboratory (JAX), a US-based non-profit biomedical research organization, announced that it will acquire Charles River Laboratories Japan’s Research Models & Services (RMS) business as a wholly owned subsidiary. The Japan-based organization, which will be called Jackson Laboratory Japan, has approximately 250 employees and three manufacturing facilities in Atsugi, Hino and Tsukuba, and an administrative office in Yokohama.

The story goes on

Market Dynamics of Humanized Mice Models:

driver

The market for humanized mouse models is expected to grow as more and more personalized medicines are made using animal models, especially mouse models. Human tissues are converted into immunodeficiency models and the signs of the disease are recorded. In order to then find the best way to treat the patient, the model is given various drugs or gene therapy. This increases the number of influencing factors on the world market. Also advances in genomics, proteomics and metabolomics; the end of the Human Genome Project; Increase in personalized diagnostics and therapies; Personalized care is becoming increasingly popular as people become more interested in health, wellness and prevention.

challenges

Although there are many reasons to use humanized models in studies, their high cost is one of the main reasons why they are not used more widely. Even for a single patient, a humanized model used in a study can cost thousands of dollars. The use of humanized models in state-funded basic research is also too expensive, which could slow down the growth of regional markets.

Regional Outlook:

In 2022, North America accounted for 41.5% of the revenue of the global humanized mouse model market. This large proportion is due to pharmaceutical companies spending more on research and development (R&D) and doing more biomedical research. The main drivers are expected to be the presence of large market players in this area and changes in the pharmaceutical and research industries. Recent studies state that rats and mice are used as models for 99.3% of all mammals in 16 major US organizations. So, the high usage rate of these models in these areas contributes to income growth. North America has seen many advances in technology that have resulted in modified mice, knock-in mice, and knock-out mice.
With a 33.4% market share, Europe was in second place. Because the number of study projects with rodent models has increased. In September 2021, a study team from Universitat Autonoma de Barcelona (UAB) in Spain produced a rat model that can show how people with Morquio A disease, or mucopolysaccharidosis type IVA, lose their ability to do things.
The Asia-Pacific humanized mouse model market is expected to witness high growth rates due to increasing private sector and government investment in life sciences, regenerative medicine research, increasing animal research and growing interest in personalized medicines. , growth in translational and biomedical research, growth in the pharmaceutical industry and increased pharmaceutical and biotechnology R&D activities in the region.

Buy this premium research report @
https://www.contrivedatuminsights.com/buy/8464/

Scope of the report:

Humanized Mouse Models Market Segments Covered:

Top Market Players:
Ingenious Targeting Laboratory, Axen, operates Genic Inc., Horizon Discovery Group PLC, HuMurine Technologies, Champions Oncology Inc. and others.

By type:

• Humanized Mouse Models

• Humanized rat models

After application:

• pharmaceutical and biotechnology companies

• contract research organizations

• Academic and research institutions

Regions and countries covered

• North America: (USA, Canada, Mexico, Rest of North America)

• Europe: (Germany, France, Italy, Spain, Great Britain, Nordic countries, Benelux Union, Rest of Europe)

• Asia Pacific: (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia Pacific)

• Middle East & Africa: (Saudi Arabia, United Arab Emirates, Egypt, South Africa, Rest of Middle East and Africa)

• Latin America: (Brazil, Argentina, rest of Latin America)

• rest of the world

Check out other related studies published by Contrive Datum Insights:

• Recovered packaging market – The global reclaimed packaging market is projected to grow at a CAGR of 6.5% from 2022 to 2030. Asia Pacific dominated the global market in terms of revenue share in 2019. The region is expected to continue its dominance over the forecast period due to high demand for corrugated boxes and wooden packaging from various end-use industries such as food and beverage retail and protective packaging.

• Gable Roof Packaging Market– The global gable end packaging market is anticipated to grow at a CAGR of 3.4% during the forecast period 2022 to 2030. Asia-Pacific is expected to emerge as a prominent region in the global gable end packaging market, accounting for the highest market share in the market revenue. The growth of the gable end packaging market in Asia Pacific is attributed to the ever expanding food and beverage industry in the region.

• Packaging robot market – The market size for packaging robots was estimated at USD 4,352.1 million in 2022 and is expected to reach USD 14,475 million by 2030 at a CAGR of 12.3% from 2022 to 2030. In terms of region, the market is divided by the Asian -dominant pacific region. China is likely to soon boast as high transaction value as high volume in the global packaging robot market. The influx of Chinese manufacturers is expected to intensify competition in the global packaging robot market in Asia-Pacific in the near future.

• Loose filled polystyrene packaging market – The global loose fill polystyrene packaging market is projected to register a CAGR of 4.1% during the forecast period. Asia-Pacific held the dominant position in terms of revenue share in the global loose-fill polystyrene packaging market in 2017, with a market share of 44.1%. End-use industries such as pharmaceutical, cosmetics and personal care industries in the region are growing rapidly and driving the growth of the market in the region.

Customization of the report: The report can be customized according to the needs or requirements of the client. If you have any questions, you can contact us at [email protected] or +1 215-297-4078. Our sales representatives are happy to understand your needs and provide you with the most suitable reports.

About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and advisory services to officials in diverse sectors including investment, information technology, telecom, consumer technology and manufacturing markets. CDI helps investment communities, executives and IT professionals make statistically informed, accurate technology purchase decisions and drive strong growth tactics to remain competitive in the marketplace. With a team size of more than 100 analysts and a cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the provision of industry knowledge combined with global and country-specific expertise.

Social networks: Facebook / LinkedIn / Twitter

Contact us:
Anna B | sales management
Invent Date Insights
Telephone: +91 9834816757 | +1 2152974078
E-mail: [email protected]

Website:
https://www.contrivedatuminsights.com
Contrive Date Insights Press Releases
Latest Contrive Date Insights Latest Reports